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and disability, issues often already assessed in trials and
which may not be of direct concern to the respondent.
Such assessments fail to account for interactions between
health status and other influences on QoL, such as eco-
nomic, social and environmental factors. The needs-based
model argues that QoL is the extent to which individuals
are able to meet their needs. Specific diseases influence
different needs and interventions are effective where they
allow more needs to be met. Relevant needs are identified
from qualitative interviews with patients. The approach
has been applied in the development of QoL instruments
specific to depression, adult growth hormone deficiency,
genital herpes, migraine, incontinence, urogenital atrophy,
male erectile difficulties, rheumatoid arthritis, care givers
of Alzheimer patients, ankylosing spondylitis, atopic der-
matitis, psoriasis, lupus and psoriatic arthritis. All lan-
guage versions of these instruments have excellent psycho-
metric properties, are sensitive to clinical improvements
and several are now the QoL instruments of choice for
clinical trials.
CONCLUSIONS: The needs-based model provides a true
“QoL” measurement that complements clinical assess-
ments of health status.
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BACKGROUND: Approaches to interpretation of qual-
ity of life changes in clinical trials have fallen into two
camps: those that rely on the distribution of changes and
the Effect Size (ES), and those that use some external an-
chor, such as patient judgements of change, which is then
used to compute a Minimally Important Difference
(MID), the proportion benefiting from treatment, p(B),
and the number needed to treat (NNT).
OBJECTIVE: To examine the relationship between the
ES and p(B), and the impact of the MID on this relation-
ship.
METHODS: We used a simulation based on a normal
distribution to compute the proportion of patients bene-
fiting in both parallel group and crossover designs, for
various values of the ES and the MID. We assessed the
agreement of the simulation with empirical data from
four studies of asthma and respiratory disease. We also
examined the effect of skewness in the distribution of
change scores on the relationship between ES and p(B).
RESULTS: The simulation showed a near-linear relation-
ship between ES and p(B), which was nearly independent
of the value of the MID. Agreement of the simulation
with the empirical data was excellent. While the curves
differed for crossover and parallel group designs, the gen-
eral form was similar. Introducing moderate skew into
the distributions had minimal impact on the relationship.
CONCLUSIONS: The proportion of patients who will
benefit from treatment can be directly estimated from the
effect size, and is nearly independent of the choice of
MID. Effect size and anchor-based approaches provide
equivalent information in this situation.
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OBJECTIVE: To compare the discriminatory power of
two different measures—graphic positioning scale (GPS)
and traditional scale (TS)—in assessing respondent ac-
ceptability of three utility measures: standard gamble
(SG), visual analogue scale (VAS) and willingness to pay
(WTP).
METHODS: Two face-to-face interviews were conducted
at least one week apart in a convenience sample of
women aged 22 to 50 years with no history of breast can-
cer or cancer requiring chemotherapy. Study participa-
tion required completion of two surveys: one evaluating
utility for an acute condition (post chemotherapy nausea
and vomiting: PCNV), and the other, for a chronic condi-
tion (breast cancer). Data were collected between March
2000 and June 2000 at a University in the Midwest US.
Respondents were randomized to either GPS or TA. A
four-way, mixed-design analysis of variance (ANOVA)—
2x(2x3x4)—was conducted, i.e., assessment (GPS/TS),
condition (acute and chronic), utility (VAS, SG, WTP)
and acceptability (difficulty, clarity, reasonableness and
comfort). Each of the four levels of acceptability was
measured on a nine-point Likert scale.
RESULTS: Analysis of 119 useable respondent surveys
showed that condition, utility, and acceptability were sig-
nificant main effects. Furthermore, ANOVA results sug-
gested three significant interactions: condition and assess-
ment; condition and acceptability; utility and acceptability.
CONCLUSION: Results of this study support Naray-
ana’s (1977) findings in the marketing literature and indi-
cate that GPS has higher discriminatory power than TS in
assessing respondent acceptability of utility measures.
These results can be explained by direct versus indirect
comparisons made with GPS and TS methods respec-
tively.
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OBJECTIVE: Postal surveys only investigate HRQOL in
those who return questionnaires and also complete
enough information for analysis. Calculation of a single
index of HRQoL (EQ-5D index) is impossible where
data are missing. This study investigates completion of
EQ-5D and the factors associated with non-completion.
METHOD: A postal questionnaire was sent to 10,471
adults registered to two general practices in Manchester.
Non-responders received reminders after four and eight
weeks. Demographic information for non-responders was
obtained from general practitioner records. Indicators of
social deprivation were obtained from the Regional Health
Authority. EQ-5D rates 5 HRQOL domains on three lev-
els with overall health state marked on a visual analogue
scale (VAS) between 0 (worst) and 100 (best).
RESULTS: In total, 6838 (65.3%) questionnaires were
returned; 5954 (56.9%) were complete. The self-care do-
main was missed most often (5.6% of responders) fol-
lowed by anxiety/depression (4.4%), usual-activities (4.3%),
pain/discomfort (4.1%), and mobility (3.9%). There was
a significant difference in proportions between self-care
and anxiety/depression (4.4% vs 5.6%, difference 
0.121, 95% CI of difference 0.195 to 0.0481). Four
hundred thirty one people missed the VAS. Women were
more likely to miss domain questions (10.2% vs 7.7%,
chi2 12.67, p  .001) as were older respondents (mean
age 47.6 vs 57.7 t 12.16, p  .001). Missing data were
less common in those with further education or a degree
(10.3% vs 5.5% and 5.3% respectively, chi2 46.4, p 
0.001). Social deprivation was more common in those
who missed a question but this was not statistically sig-
nificant.
CONCLUSION: Low levels of non-completion were
found, although respondents were significantly less will-
ing to answer about self-care than about other domains,
possibly not wishing to appear dependent on others. The
importance of analyzing the degree of non-completion of
a questionnaire and possible associated factors should be
noted. Future work is needed to investigate HRQoL in
those who do not respond to or complete questionnaires.
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Anemia at diagnosis (baseline) is a potential adverse
prognostic factor for no response to chemotherapy in ad-
dition to the standard risk factors.
OBJECTIVE: The purpose of this study was to identify
factors associated with baseline anemia and to determine
risk factors associated with no response to CHOP che-
motherapy in IGNHL patients.
METHODS: A historical case series sample of 591 pa-
tients diagnosed between 1993 and 1999, and treated in
12 practice sites with CHOP chemotherapy was used.
Baseline anemia was defined as a hemoglobin (Hb) value
12 g/dl at baseline. Multiple logistic regression was
used to determine factors associated with baseline anemia
and model its relationship with response [no response
(NR) versus partial response (PR) and complete response
(CR)].
RESULTS: Anemia was present in 193/546 (35.3%) pa-
tients. Baseline Hb values were not available for 45 pa-
tients. Multiple logistic regression showed that baseline
anemia was significantly associated with elevated LDH
(OR; 95%CI) (OR  2.74; 1.66–4.50), presence of B
symptoms (OR  2.16; 1.22–3.83), stage III-IV (OR 
1.81: 1.10–2.93), male gender (0.42: 0.25–0.69), and
large cell diffuse (OR  2.05; 1.19–3.54) or immuno-
blast (3.99; 1.78–9.02) histologic types. No significant
interactions existed between any of the variables included
in this model. Multiple logistic regression (predicting NR
versus CR/PR) showed that the presence of baseline anemia
(OR  2.29; 1.10–4.74) controlling for elevated LDH,
advanced Stage III-IV, and age greater than or equal to
60, was a significant risk factor for NR to CHOP chemo-
therapy.
CONCLUSION: The results support previous findings of
the high prevalence of, and risk factors associated with,
baseline anemia prior to CHOP chemotherapy. Baseline
anemia was a significant risk factor for NR to CHOP
chemotherapy, even after controlling for age, stage, and
LDH. We conclude that additional studies with a com-
prehensive set of known risk factors validating this rela-
tionship between baseline anemia and response to CHOP
chemotherapy are warranted.
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OBJECTIVE: Breast cancer is one of the major causes of
premature death for women. The management of its cost is
important for both the national health insurance and the in-
dividual health-care providers. The objective of this study
was to assess the global medical cost of breast cancer, from
diagnosis to follow up, in a French medical centre.
METHODS: Our evaluation was based on a retrospec-
tive cohort of 120 patients followed from January 1995
to February 2000 at Centre René Huguenin (Saint-
Cloud). Comprehensive treatment schemes and clinical
events were reported from patients’ medical files. De-
tailed medical consumptions and mean duration of staff
occupation were obtained primarily from direct observa-
